Enforcement Report - Week of December 6, 2023
Enforcement Report - Week of October 25, 2023
Enforcement Report - Week of June 7, 2023
Represents the first FDA approved fixed-combination of tropicamide and phenylephrine for mydriasis Provides critical validation of key technology that is core to Eyenovia€™s proprietary development...
Enforcement Report - Week of January 25, 2023
Enforcement Report - Week of February 2, 2022
KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products
JCB Laboratories Receives Form 483
Enforcement Report - Week of October 31, 2018
A supply disruption alert was issued by the Department of Health & Social Care (DHSC) on EpiPen and EpiPen Junior; see MHRA advice on extension of use beyond the expiry date for certain batches of EpiPen 300 microgram adrenaline autoinjectors. MHRA issued alerts and recalls for batches of Olmetec, Mydriasert, Caspofungin, and Imatinib.